Ignite Creation Date:
2025-12-25 @ 3:10 AM
Ignite Modification Date:
2026-01-08 @ 7:33 PM
Study NCT ID:
NCT05060705
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-04-17
First Post:
2021-09-24
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
"Efesovir" (FS-1) for COVID-19, Phase 2
Sponsor:
Scientific Center for Anti-infectious Drugs, Kazakhstan
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CTP-FS-1-SE-2-05
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None